ID
15841
Description
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00146588
Link
https://clinicaltrials.gov/show/NCT00146588
Keywords
Versions (1)
- 6/15/16 6/15/16 -
Uploaded on
June 15, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00146588
Eligibility Breast Cancer NCT00146588
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnancy or lactating
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
prior malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
Description
anthracycline therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0282564
Description
comorbidity
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Similar models
Eligibility Breast Cancer NCT00146588
- StudyEvent: Eligibility
C0175795 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])